Your browser doesn't support javascript.
loading
Functionalized Prussian Blue Nanozyme as Dual-Responsive Drug Therapeutic Nanoplatform Against Maxillofacial Infection via Macrophage Polarization.
Da, Junlong; Li, Ying; Zhang, Kai; Ren, Junyu; Wang, Jianqun; Liu, Xinpeng; Liu, Xiaoyao; Zhang, Jiahui; Liu, Lixue; Zhang, Wenxuan; Zhang, Shujian; Guo, Yuyao; Zhang, Bin; Jin, Han.
Affiliation
  • Da J; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Li Y; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Zhang K; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Ren J; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Wang J; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Liu X; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Liu X; Department of Orthodontics, the First Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Zhang J; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Liu L; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Zhang W; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Zhang S; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Guo Y; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Zhang B; Heilongjiang Provincial Key Laboratory of Hard Tissue Development and Regeneration, the Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Jin H; Heilongjiang Academy of Medical Sciences, Harbin, People's Republic of China.
Int J Nanomedicine ; 17: 5851-5868, 2022.
Article in En | MEDLINE | ID: mdl-36474527
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Macrophages / Anti-Inflammatory Agents Language: En Journal: Int J Nanomedicine Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Macrophages / Anti-Inflammatory Agents Language: En Journal: Int J Nanomedicine Year: 2022 Type: Article